Neovascular Age-related Macular Degeneration
📧 Sign up to get email alerts when something new happens for Neovascular Age-related Macular Degeneration.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-12-29Clinical Trial Update: Intravitreal Brolucizumab in Neovascular Age-related Macular Degeneration With Limited Response to Aflibercept [Phase 4]
Clinical trial update for intravitreal brolucizumab in neovascular age-related macular degeneration with limited response to aflibercept; st…
-
CLINICAL_TRIALS trial_result · 2021-06-24Clinical Trial Update: Efficacy and Safety Trial of Conbercept Intravitreal Injection for Neovascular AMD (PANDA-1) [Phase 3]
Phase 3 trial of intravitreal conbercept for neovascular age-related macular degeneration was terminated.
-
CLINICAL_TRIALS trial_result · 2021-06-23Clinical Trial Update: Efficacy and Safety Trial of Conbercept Intravitreal Injection for Neovascular AMD (PANDA-2) [Phase 3]
Phase 3 trial of intravitreal conbercept for neovascular age-related macular degeneration was terminated.
-
CLINICAL_TRIALS trial_result · 2021-04-23Clinical Trial Update: A Study To Evaluate CKD-701 and Lucentis® in Patients With Neovascular(Wet) Age Related Macular Degeneration [Phase 3]
APhase 3 trial evaluating CKD-701 and Lucentis in neovascular (wet) age-related macular degeneration has completed.
-
CLINICAL_TRIALS trial_result · 2021-04-08Clinical Trial Update: Efficacy and Safety of Two Different Aflibercept Regimens in Subjects With Neovascular Age-related Macular Degeneration (nAMD) [Phase 3]
Phase 3 trial update comparing two aflibercept regimens in neovascular age-related macular degeneration completed with posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-01-12Clinical Trial Update: A Dose Ranging Study of OPT-302 With Ranibizumab in Neovascular (Wet) AMD [Phase 2]
Phase 2 dose-ranging study of OPT-302 with ranibizumab in neovascular age-related macular degeneration completed.
-
CLINICAL_TRIALS trial_result · 2021-01-05Clinical Trial Update: Study to Evaluate Faricimab (RO6867461; RG7716) for Extended Durability in the Treatment of Neovascular Age Related Macular Degeneration [Phase 2]
Phase 2 trial update evaluating faricimab for extended durability in neovascular age-related macular degeneration (nAMD) has completed with …
-
CLINICAL_TRIALS trial_result · 2020-12-19Clinical Trial Update: Safety and Efficacy of Intravitreal LFG316 in Wet Age Related Macular Degeneration (AMD) [Phase 2]
Phase 2 trial update on intravitreal LFG316 for wet age-related macular degeneration showing safety and efficacy data.
-
CLINICAL_TRIALS trial_result · 2020-11-06Clinical Trial Update: Safety and Tolerability Study for Age-Related Macular Degeneration [Phase 1, Phase 2]
A completed Phase 1/2 safety and tolerability study for neovascular age-related macular degeneration.
-
CLINICAL_TRIALS trial_result · 2020-11-04Clinical Trial Update: Safety and Efficacy of AS101 1% Oral Solution in Patients With Neovascular Age-Related Macular Degeneration (AMD) [Phase 1, Phase 2]
Phase 1/2 trial update evaluating safety and efficacy of AS101 1% oral solution in neovascular age-related macular degeneration has complete…
-
CLINICAL_TRIALS trial_result · 2020-10-26Clinical Trial Update: Study of Intravitreal REGN2176-3 in Participants With Neovascular ("Wet") Age-Related Macular Degeneration (AMD) [Phase 2]
Phase 2 trial of intravitreal REGN2176-3 for neovascular age-related macular degeneration was terminated with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-10-06Clinical Trial Update: Assessment of Safety, Tolerability and Pharmacokinetics of Intravitreal Pegcetacoplan (APL-2) for Patients With Wet AMD [Phase 1]
Phase 1 trial assessing safety, tolerability, and pharmacokinetics of intravitreal pegcetacoplan (APL-2) for neovascular age-related macular…
-
CLINICAL_TRIALS trial_result · 2020-09-16Clinical Trial Update: Pegcetacoplan (APL-2) in Neovascular AMD [Phase 1, Phase 2]
Phase 1/2 trial of pegcetacoplan (APL-2) in neovascular age-related macular degeneration was terminated; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-09-02Clinical Trial Update: Study Investigating OCT, Multifocal ERG, and Microperimetry in Monthly Versus PRN Ranibizumab in Neovascular Age-Related Macular Degeneration [Phase 2, Phase 3]
A Phase 2/3 clinical trial comparing monthly versus PRN ranibizumab in neovascular age-related macular degeneration has completed with resul…
-
CLINICAL_TRIALS trial_result · 2020-08-03Clinical Trial Update: Study of the Safety of Brolucizumab 6 mg in Prefilled Syringe in Patients With Neovascular Age Related Macular Degeneration [Phase 3]
A Phase 3 trial update assessing the safety of brolucizumab 6 mg in a prefilled syringe for neovascular age-related macular degeneration.
-
CLINICAL_TRIALS trial_result · 2020-06-19Clinical Trial Update: Dorzolamide-timolol in Combination With Anti-vascular Endothelial Growth Factor Injections for Wet Age-related Macular Degeneration [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial evaluating dorzolamide-timolol in combination with anti-VEGF injections for neovascular/wet age-related mac…
-
CLINICAL_TRIALS trial_result · 2020-04-30Clinical Trial Update: Study of Safety and Efficacy of Brolucizumab 6 mg Drug Product Intended for Commercialization in Patients With nAMD [Phase 3]
Phase 3 trial update for brolucizumab 6 mg in neovascular age-related macular degeneration has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-10-31Clinical Trial Update: Efficacy and Safety of RTH258 Versus Aflibercept - Study 1 [Phase 3]
Completed Phase 3 trial (Study 1) comparing RTH258 (brolucizumab) with aflibercept in neovascular age-related macular degeneration, with eff…
-
CLINICAL_TRIALS trial_result · 2019-10-31Clinical Trial Update: Efficacy and Safety of RTH258 Versus Aflibercept - Study 2 [Phase 3]
A Phase 3 study comparing RTH258 (brolucizumab) to aflibercept in neovascular age-related macular degeneration focuses on efficacy and safet…
-
CLINICAL_TRIALS trial_result · 2019-08-20Clinical Trial Update: Evaluation of the Usefulness of a Treat and Extend Regimen Using Ranibizumab for Neovascular AMD. [Phase 4]
Phase 4 trial evaluating the usefulness of a treat-and-extend regimen using ranibizumab for neovascular age-related macular degeneration (AM…
-
CLINICAL_TRIALS trial_result · 2019-07-09Clinical Trial Update: Study of PAN-90806 Eye Drops, Suspension for Neovascular AMD [Phase 1, Phase 2]
Phase 1/2 clinical trial update for PAN-90806 eye drops in neovascular age-related macular degeneration has completed.
-
CLINICAL_TRIALS trial_result · 2019-05-07Clinical Trial Update: Anti-angiOpoeitin 2 Plus Anti-vascular eNdothelial Growth Factor as a therapY for Neovascular Age Related Macular Degeneration: Evaluation of a fiXed Combination Intravitreal Injection [Phase 2]
Phase 2 clinical trial evaluating a fixed combination intravitreal injection targeting anti-angiopoietin 2 and anti-VEGF for neovascular age…
-
CLINICAL_TRIALS trial_result · 2019-04-17Clinical Trial Update: Post Intravitreal Injection Topical NSAID vs. Patching [Phase 4]
A Phase 4 trial update comparing post-intravitreal injection topical NSAID versus patching for neovascular age-related macular degeneration …
-
CLINICAL_TRIALS trial_result · 2019-03-21Clinical Trial Update: Efficacy of Ranibizumab Prn Treatment Compared to Aflibercept Bimonthly Intravitreal Injections on Retinal Thickness Stability in Patients With Wet AMD [Phase 4]
Phase 4 trial comparing ranibizumab on an as-needed basis to aflibercept every two months for maintaining retinal thickness stability in neo…
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Safety and Efficacy of Switching From Aflibercept to Ranibizumab in Patients With nAMD [Phase 4]
Phase 4 trial evaluating safety and efficacy of switching from aflibercept to ranibizumab in patients with neovascular age-related macular d…